Literature DB >> 20443834

Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.

David S Zuzga1, Ahmara Vivian Gibbons, Peng Li, Wilhelm Johannes Lubbe, Inna Chervoneva, Giovanni Mario Pitari.   

Abstract

Colorectal cancer mortality largely reflects metastasis, the spread of the disease to distant organs. Matrix metalloproteinase 9 (MMP-9) is a key regulator of metastasis and a target for anticancer strategies in colon cancer. Here, the overexpression of MMP-9 in pure tumor epithelial, but nor stromal, cell populations was associated with metastatic progression of colorectal cancer, as defined by reverse transcriptase-polymerase chain reaction (qRT-PCR) and confirmed by immunostaining. Thus, cancer cell MMP-9 represents a novel, selective prognostic and predictive factor that may be exploited for more effective disease stage stratification and therapeutic regimen selection in patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20443834      PMCID: PMC5439552          DOI: 10.1111/j.1752-8062.2008.00037.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  24 in total

Review 1.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

Review 2.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

Review 3.  New directions in the treatment of colorectal cancer: a look to the future.

Authors:  A Sobrero; D Kerr; B Glimelius; E Van Cutsem; G Milano; D M Pritchard; P Rougier; M Aapro
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

Review 4.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

5.  Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

Authors:  Z S Zeng; Y Huang; A M Cohen; J G Guillem
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

Review 6.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

7.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

Review 8.  Colon cancer overview.

Authors:  P Greenwald
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

9.  Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism.

Authors:  David Murray; Mary Morrin; Susan McDonnell
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

10.  Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.

Authors:  Wilhelm J Lubbe; Zengyi Y Zhou; Weili Fu; David Zuzga; Stephanie Schulz; Rafael Fridman; Ruth J Muschel; Scott A Waldman; Giovanni M Pitari
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

View more
  4 in total

1.  Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.

Authors:  Wilhelm J Lubbe; David S Zuzga; Zengyi Zhou; Weili Fu; Joshua Pelta-Heller; Ruth J Muschel; Scott A Waldman; Giovanni M Pitari
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

Review 2.  Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects.

Authors:  Asma Ismail Mahmod; Shatha Khaled Haif; Ayah Kamal; Israa A Al-Ataby; Wamidh H Talib
Journal:  Front Nutr       Date:  2022-08-04

Review 3.  MicroRNAs in cancer metastasis and angiogenesis.

Authors:  Weiyang Lou; Jingxing Liu; Yanjia Gao; Guansheng Zhong; Danni Chen; Jiaying Shen; Chang Bao; Liang Xu; Jie Pan; Junchi Cheng; Bisha Ding; Weimin Fan
Journal:  Oncotarget       Date:  2017-12-11

4.  The downregulation of Rap1 GTPase-activating protein is associated with a poor prognosis in colorectal cancer and may impact on tumor progression.

Authors:  Wei-Li Gao; Guo-Chao Ye; Li-Wei Liu; Lu Wei
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.